Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement

Laura Van den Bergh, Steven Joniau, Karin Haustermans*, Christophe M. Deroose, Sofie Isebaert, Raymond Oyen, Felix M. Mottaghy, Filip Ameye, Joost Berkers, Hendrik Van Poppel, Evelyne Lerut

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

PURPOSE Accurate staging modalities to diagnose lymph node involvement in patients with prostate cancer (PCa) are lacking. We wanted to prospectively assess sensitivity, specificity, and positive predictive value (PPV) and negative predictive value of (11)C-choline positron emission tomography (PET)-computed tomography (CT) and diffusion-weighted (DW) magnetic resonance imaging (MRI) for nodal staging in patients with PCa at high risk for lymph node involvement. MATERIAL AND METHODS In total, 75 patients with a risk≥10% but
Original languageEnglish
Pages (from-to)896-902
Number of pages7
JournalActa Oncologica
Volume54
Issue number6
DOIs
Publication statusPublished - 3 Jul 2015

Keywords

  • Diffusion-weighted magnetic resonance imaging
  • Lymph nodes
  • Positron emission tomography
  • Prostatic neoplasms
  • Staging

Fingerprint

Dive into the research topics of 'Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement'. Together they form a unique fingerprint.

Cite this